Dr. Insa has worked for more than 30 years in multinational pharmaceutical companies such as Parke-Davis (now Pfizer), UCB Pharma, Uriach Group (now Palau Pharma), and ISDIN (from Esteve Group), before establishing SOM Biotech. His experience is in drug development, from drug identification to commercialization, including clinical research and licensing. He was involved in the development of products like Quinapril, Tacrine, Cetirizine, Levetiracetam, Rupatadine, Dersalazine, Cimicoxib, Albaconazole, Gemfibrozil, Gabapentin, Piracetam, Levocetirizine, Nanocapsuled Cyclosporin, Disitertide, and others. He received his medical training and his PhD in Clinical Neurology from the University of Alicante, Spain; an MBA from ESADE Business School in Barcelona, and an Executive Education Program from IESE, Barcelona. He has also attended biotech leadership programs at Harvard Business School, Boston. His background includes more than 45 publications and papers, 7 chapters in books, 87 congress communications, and 9 pharmaceutical patents.